Business Context and Reporting Period
This Form 8-K was filed by MRI Interventions, Inc. on July 26, 2016. The report details a material corporate action involving a 1-for-40 reverse stock split of the company's common stock, effective as of 4:01 p.m. Eastern Time on the filing date. The company is incorporated in Delaware and maintains its principal executive offices in Irvine, California.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. The document focuses exclusively on the structural change to the company's capitalization.
Material Changes Versus Prior Period
- Share Count Reduction: The number of outstanding common shares was reduced from approximately 96.1 million to approximately 2.4 million.
- Stock Split Ratio: A 1-for-40 reverse stock split was implemented.
- Authorized Shares: The total number of authorized shares of common stock under the Certificate of Incorporation remains unchanged.
- Derivative Adjustments: Proportionate adjustments were made to the per-share exercise price and the number of shares underlying all outstanding options and warrants.
- Equity Plans: The number of shares reserved for issuance pursuant to equity compensation plans was reduced proportionately.
- Identification: The new CUSIP number for the common stock is 55347P 209.
Guidance, Outlook, and Risks
Purpose: The reverse stock split is intended to permit the company to meet one of the listing criteria for The Nasdaq Capital Market.
Risks and Contingencies: Management explicitly states that there can be no assurance that the company will be able to satisfy all of the listing criteria for The Nasdaq Capital Market following this action.
Shareholder Impact: Stockholders holding shares in electronic form at brokerage firms require no action, as the split will be automatically reflected. Stockholders holding physical certificates will receive a transmittal letter from the transfer agent to obtain new certificates with the updated CUSIP number.
Important Facts for Investor Verification
- Verify the current trading price and volume of the stock under the new CUSIP number (55347P 209).
- Confirm whether the company has successfully met all remaining listing criteria for The Nasdaq Capital Market.
- Check for any subsequent filings regarding the status of the company's listing or potential delisting notices.
- Review the adjusted terms of any outstanding options or warrants held by the investor.